Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 4 studies | 19% ± 2% | |
GABAergic neuron | 3 studies | 29% ± 7% | |
glutamatergic neuron | 3 studies | 40% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 26% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 1892.94 | 89 / 89 | 100% | 19.93 | 901 / 901 |
liver | 100% | 1809.27 | 226 / 226 | 100% | 13.74 | 406 / 406 |
prostate | 100% | 2225.26 | 245 / 245 | 100% | 19.71 | 502 / 502 |
stomach | 100% | 1283.95 | 359 / 359 | 100% | 9.08 | 286 / 286 |
thymus | 100% | 2024.85 | 653 / 653 | 100% | 20.50 | 605 / 605 |
brain | 100% | 2527.63 | 2641 / 2642 | 100% | 25.57 | 705 / 705 |
pancreas | 100% | 1129.43 | 327 / 328 | 100% | 12.14 | 178 / 178 |
skin | 100% | 1455.62 | 1809 / 1809 | 100% | 12.77 | 470 / 472 |
uterus | 100% | 1674.15 | 170 / 170 | 100% | 11.19 | 457 / 459 |
breast | 100% | 1980.55 | 459 / 459 | 100% | 18.61 | 1113 / 1118 |
ovary | 100% | 2012.54 | 180 / 180 | 100% | 10.24 | 428 / 430 |
esophagus | 100% | 1276.49 | 1445 / 1445 | 99% | 7.73 | 182 / 183 |
adrenal gland | 100% | 1783.82 | 258 / 258 | 99% | 14.50 | 228 / 230 |
lung | 99% | 1346.29 | 573 / 578 | 100% | 12.11 | 1152 / 1155 |
intestine | 100% | 1571.33 | 966 / 966 | 99% | 10.32 | 521 / 527 |
bladder | 100% | 1524.05 | 21 / 21 | 99% | 10.13 | 498 / 504 |
adipose | 100% | 1406.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 15.83 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 12.05 | 29 / 29 |
spleen | 100% | 1675.20 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.80 | 1 / 1 |
muscle | 100% | 1587.85 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1228.83 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1923.88 | 847 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 9.43 | 44 / 45 |
peripheral blood | 86% | 786.77 | 803 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902553 | Biological process | positive regulation of catalase activity |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0006476 | Biological process | protein deacetylation |
GO_2000378 | Biological process | negative regulation of reactive oxygen species metabolic process |
GO_0006338 | Biological process | chromatin remodeling |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_2000304 | Biological process | positive regulation of ceramide biosynthetic process |
GO_0034983 | Biological process | peptidyl-lysine deacetylation |
GO_1901671 | Biological process | positive regulation of superoxide dismutase activity |
GO_0009060 | Biological process | aerobic respiration |
GO_0005739 | Cellular component | mitochondrion |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0003950 | Molecular function | NAD+ ADP-ribosyltransferase activity |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0017136 | Molecular function | NAD-dependent histone deacetylase activity |
GO_0070403 | Molecular function | NAD+ binding |
GO_0034979 | Molecular function | NAD-dependent protein lysine deacetylase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_1990404 | Molecular function | NAD+-protein ADP-ribosyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SIRT3 |
Protein name | Sirtuin 3 NAD-dependent protein deacetylase (EC 2.3.1.286) NAD-dependent protein deacetylase sirtuin-3, mitochondrial (hSIRT3) (EC 2.3.1.286) (Regulatory protein SIR2 homolog 3) (SIR2-like protein 3) |
Synonyms | SIR2L3 |
Description | FUNCTION: NAD-dependent protein deacetylase . Activates or deactivates mitochondrial target proteins by deacetylating key lysine residues . Known targets include ACSS1, IDH, GDH, SOD2, PDHA1, LCAD, SDHA and the ATP synthase subunit ATP5PO . Contributes to the regulation of the cellular energy metabolism . Important for regulating tissue-specific ATP levels . In response to metabolic stress, deacetylates transcription factor FOXO3 and recruits FOXO3 and mitochondrial RNA polymerase POLRMT to mtDNA to promote mtDNA transcription . Acts as a regulator of ceramide metabolism by mediating deacetylation of ceramide synthases CERS1, CERS2 and CERS6, thereby increasing their activity and promoting mitochondrial ceramide accumulation (By similarity). Regulates hepatic lipogenesis. Uses NAD(+) substrate imported by SLC25A47, triggering downstream activation of PRKAA1/AMPK-alpha signaling cascade that ultimately downregulates sterol regulatory element-binding protein (SREBP) transcriptional activities and ATP-consuming lipogenesis to restore cellular energy balance. . FUNCTION: NAD-dependent protein deacetylase. . |
Accessions | ENST00000382743.9 [Q9NTG7-1] E9PM52 ENST00000526854.5 ENST00000525237.1 ENST00000529382.5 [Q9NTG7-2] ENST00000529055.5 ENST00000528469.1 E9PIT6 ENST00000532837.5 Q9NTG7 ENST00000525776.1 ENST00000525319.5 ENST00000524564.5 E9PNA0 ENST00000529937.1 E9PN58 E9PJS6 ENST00000530067.1 B7WNN4 E9PR48 ENST00000532956.5 E9PM75 E9PK80 |